Latest Articles
- A 61-year-old man with fluctuating hypertension
In this patient with diabetes, an episode of hypoglycemia led to an unexpected discovery.
- Does massive hemoptysis always merit diagnostic bronchoscopy?
The procedure can control the airway, find the source of the bleeding, and in some cases stop it.
- Why are we doing cardiovascular outcome trials in type 2 diabetes?
Lowering blood glucose alone may not reduce adverse cardiovascular events.
- Diabetes management: More than just cardiovascular risk?
Inadequate glycemic control remains the leading cause of blindness, kidney failure, and nontraumatic lower-limb amputation.
- Women and HIV: An expanded perspective
HIV preys on the vulnerable. Testing is crucial. Pre-exposure prophlyaxis is an attractive concept but an incomplete solution.
- Acute respiratory distress syndrome: Implications of recent studies
A review of the new definition of this disease and new important studies of ventilatory and nonventilatory therapies.
- Diabetes therapy and cancer risk: Where do we stand when treating patients?
Several classes of diabetes drugs are under scrutiny for potentially promoting cancer in a population already at risk.
- To dream the maybe possible dream: A breast cancer vaccine
The work is in an extremely preliminary phase, but the concept is an active area of research worth keeping tabs on.
- Bench-to-bedside challenges in developing immune protection against breast cancer
A vaccine against breast cancer is being developed. Here, the author explains the principles and challenges.
- Keeping up with immunizations for adults
Flu, tetanus, measles, mumps, rubella, varicella, hepatitis A and B, human papillomavirus, zoster, pneumonia, and meningitis.